Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Roquette to make second investment in Vic-sur-Aisne plant

    Roquette—a world leader in nutrition from innovative plant-based ingredients—is set to strengthen its presence in Hauts-de-France by investing €40 million in pea proteins in Aisne.

    Rigby Group chooses Hauts-de-France

    Rigby Group subsidiary Altimance, an IT services specialist, will soon begin operations in Valenciennes, joining La Serre Numérique, La Nouvelle Forge and La Cité des Congrès in the Rives Créatives de l’Escaut...

    All news

    Lille’s Macopharma uses cell therapy to fight diabetes

    07 Apr 2015 | Health Nutrition, A region on the move

    Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

    Macopharma innovation - Health- Lille Region

    Prisma—a pioneer in diabetes therapy

    Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

    Patented technology, bold commercial roll-out

    Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

     

     

    Source: Les Echos, Nicole Buyse

     

     

    Back to news